We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3026
DBV Technologies S.A. American Depositary Shares
DBVT
$573M
| – | – |
-43
| Closed | -$1K | – |
|
3027
Delcath Systems
DCTH
$514M
| $0 | ﹤0.01% |
1
| – | – |
2020 Q2
7 quarters
|
|
3028
3D Systems Corp
DDD
$492M
| $0 | ﹤0.01% |
21
| – | – |
2016 Q4
21 quarters
|
|
3029
DELISTED
Denny's
DENN
| – | – |
-219
| Closed | -$4K | – |
|
3030
Donnelley Financial Solutions
DFIN
$1.26B
| $0 | ﹤0.01% |
+3
| New | +$107 |
2022 Q1
0 quarters
|
|
3031
Digi International
DGII
$2.72B
| $0 | ﹤0.01% |
21
| – | – |
2021 Q1
4 quarters
|
|
3032
Dine Brands
DIN
$418M
| – | – |
-5
| Closed | – | – |
|
3033
Global X SuperDividend US ETF
DIV
$764M
| – | – |
-215
| Closed | -$4K | – |
|
3034
Delek US
DK
$4.71B
| – | – |
-39
| Closed | -$1K | – |
|
3035
Duluth Holdings
DLTH
$152M
| – | – |
-103
| Closed | -$1.44K | – |
|
3036
DoubleLine Yield Opportunities Fund
DLY
$636M
| $0 | ﹤0.01% |
20
| – | – |
2021 Q4
1 quarter
|
|
3037
DELISTED
Dun & Bradstreet
DNB
| – | – |
-194
| Closed | -$4K | – |
|
3038
Denali Therapeutics
DNLI
$2.93B
| $0 | ﹤0.01% |
2
-44
| -96% | -$1.51K |
2021 Q3
2 quarters
|
|
3039
Douglas Elliman
DOUG
$135M
| $0 | ﹤0.01% |
+45
| New | +$341 |
2022 Q1
0 quarters
|
|
3040
GrafTech
EAF
$192M
| $0 | ﹤0.01% |
1
-3
| -75% | -$312 |
2021 Q4
1 quarter
|
|
3041
Ecovyst
ECVT
$1.11B
| $0 | ﹤0.01% |
9
-19
| -68% | -$199 |
2021 Q3
2 quarters
|
|
3042
Editas Medicine
EDIT
$375M
| – | – |
-139
| Closed | -$4K | – |
|
3043
Enterprise Financial Services Corp
EFSC
$2.15B
| – | – |
-6
| Closed | -$294 | – |
|
3044
Eldorado Gold
EGO
$9.45B
| $0 | ﹤0.01% |
+20
| New | +$205 |
2022 Q1
0 quarters
|
|
3045
e.l.f. Beauty
ELF
$6.85B
| $0 | ﹤0.01% |
+4
| New | +$109 |
2022 Q1
0 quarters
|
|
3046
Elme Communities
ELME
$156M
| – | – |
-835
| Closed | -$22K | – |
|
3047
Enerpac Tool Group
EPAC
$1.79B
| – | – |
-5
| Closed | – | – |
|
3048
Edgewell Personal Care
EPC
$1.3B
| – | – |
-13
| Closed | -$1K | – |
|
3049
Essential Properties Realty Trust
EPRT
$5.61B
| $0 | ﹤0.01% |
4
-89
| -96% | -$2.29K |
2020 Q3
6 quarters
|
|
3050
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-1,526
| Closed | -$8K | – |
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.